§ PHARMACEUTICALS
USD · PharmaceuticalsHROW
HARROW INC
USDSector · PharmaceuticalsBeta · 0.22
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
127 increased/new, 72 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 34.60 | EPS (TTM) | -0.41 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Opaleye Management Inc. | 2.8M | 13.2% | n/a |
| BlackRock, Inc. | 2.6M | 0.0% | −1% |
| Private Capital Management, LLC | 1.6M | 5.5% | −15% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.4M | n/a | n/a |
| Luxor Capital Group, LP | 1.1M | 2.8% | +22% |
| State Street | 855K | 0.0% | +9% |
◇ AC INTELLIGENCE
Top institutional owners for HROW as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER98.4% · 0 holders
OTHER1.0% · 146 holders
PASSIVE / INDEX0.3% · 9 holders
DEALER / BANK0.1% · 26 holders
SYSTEMATIC / QUANT0.1% · 12 holders
QUALITY / COMPOUNDER0.1% · 13 holders
TACTICAL / MACRO0.0% · 1 holder
INCOME / DEFENSIVE0.0% · 11 holders
ACTIVIST0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for HROW in the last 180 days.